PPCB

Propanc Biopharma, Inc. PPCB

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PPCB RAIN OCEA HEPA IOVA ENDV HIPH PURA BRTX RLBD
6M -81.66 % 79.10 % -87.12 % -83.27 % -37.24 % -50.00 % 900.00 % 400.00 % -10.11 % -90.00 %
YTD -92.38 % -34.25 % -98.99 % -99.74 % -72.53 % -85.71 % 9 900.00 % 4 900.00 % 7.38 % -90.00 %
1Y -91.29 % -34.25 % -99.34 % -99.78 % -78.10 % -90.00 % 9 900.00 % 4 900.00 % -5.33 % -99.98 %
3Y -23.75 % -34.25 % -99.94 % -99.99 % -75.82 % -98.75 % -91.67 % -98.00 % -52.38 % -99.05 %
5Y -99.95 % -34.25 % -99.94 % -100.00 % -93.82 % -99.88 % -95.83 % -99.52 % -97.14 % -99.55 %
10Y -100.00 % -34.25 % -99.94 % -100.00 % -64.39 % -100.00 % -100.00 % -99.91 % -99.99 % -99.86 %
From the beginning -100.00 % -34.25 % -99.94 % -100.00 % -98.05 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend